Skip to main content
. 2017 May 25;6:22–30. doi: 10.1016/j.omto.2017.05.005

Figure 2.

Figure 2

In Vitro rRp450-Mediated Cytotoxicity

The viability of AT/RT (BT-12, BT-16) and medulloblastoma (D283med, D425med) cells following administration of rRp450 at an MOI of 0.01, 0.1, and 1. The number of viable cells was determined daily for 4 days and normalized against the number of mock-infected cells. Means ± SEM are shown (n = 8).